Literature DB >> 34004104

[Clinical practice guidelines for acute and chronic thyroiditis (excluding autoimmune thyroiditis)].

E A Troshina1, E A Panfilova1, M S Mikhina1, I V Kim1, E S Senyushkina1, A A Glibka1, B M Shifman1, A A Larina1, M S Sheremeta1, M V Degtyarev1, P O Rumyanstsev1, N S Kuznetzov1, G A Melnichenko1, I I Dedov1.   

Abstract

Acute and chronic thyroid diseases are the most frequently detected disorders being second only to diabetes mellitus.The World Health Organization points out that thyroid diseases' incidence tends to grow every year. The present paper consists of clinical practice guidelines that consider etiology, clinical course, diagnostics and treatment of acute and chronic inflammatory thyroid diseases (except those of autoimmune type).The clinical practice guidelines provide an important working tool for clinicians including specialty physicians and medical experts. Containing structured and concise information on the specific nosology, diagnostic methods and treatment tips these guidelines allow medical specialists to quickly resolve difficulties and choose the most efficient and personalized treatment (following strict principles of evidence-based medicine at the same time).The clinical practice guidelines were drawn up by highly-skilled professional team of specialty physicians approved by the Expert Council of Russian Federation's Health Department. These guidelines contain the most complete and up-to-date information required to diagnose acute and chronic thyroiditis, provide patient care and treatment.The working group publishes the present paper in the professional journal dealing with endocrinology topics to improve healthcare quality and refine treatment of acute and chronic thyroiditis (autoimmune thyroiditis excluded). It is advisable to acquaint as many endocrinology and general (family) medicine specialists as possible with the full text of these clinical guidelines.

Entities:  

Mesh:

Year:  2021        PMID: 34004104      PMCID: PMC8926135          DOI: 10.14341/probl12747

Source DB:  PubMed          Journal:  Probl Endokrinol (Mosk)        ISSN: 0375-9660


  138 in total

1.  The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis.

Authors:  L Tomisti; C Urbani; G Rossi; F Latrofa; C Sardella; L Manetti; I Lupi; C Marcocci; L Bartalena; O Curzio; E Martino; F Bogazzi
Journal:  J Endocrinol Invest       Date:  2016-01-13       Impact factor: 4.256

Review 2.  Is Hyperthyroidism Diagnosed and Treated Appropriately in the United States?

Authors:  Ammar Asban; Sophie Dream; Brenessa Lindeman
Journal:  Adv Surg       Date:  2019-05-18

3.  Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes.

Authors:  Anuradha Balasubramanian; Ramesh K Ganju; Jerome E Groopman
Journal:  J Infect Dis       Date:  2006-07-18       Impact factor: 5.226

4.  Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder.

Authors:  Jon McClellan; Robert Kowatch; Robert L Findling
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-01       Impact factor: 8.829

Review 5.  Amiodarone and the thyroid.

Authors:  Shehzad Basaria; David S Cooper
Journal:  Am J Med       Date:  2005-07       Impact factor: 4.965

6.  Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.

Authors:  F Bogazzi; E Martino; E Dell'Unto; S Brogioni; C Cosci; F Aghini-Lombardi; C Ceccarelli; A Pinchera; L Bartalena; L E Braverman
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

7.  Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism.

Authors:  Neru Munshi; Anuradha Balasubramanian; Margaret Koziel; Ramesh K Ganju; Jerome E Groopman
Journal:  J Infect Dis       Date:  2003-09-30       Impact factor: 5.226

Review 8.  The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.

Authors:  Jamie C Mandac; Sonal Chaudhry; Kenneth E Sherman; Yaron Tomer
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

9.  Meta-Analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo.

Authors:  Mohammed Ruzieh; Morgan K Moroi; Nader M Aboujamous; Mehrdad Ghahramani; Gerald V Naccarelli; John Mandrola; Andrew J Foy
Journal:  Am J Cardiol       Date:  2019-09-26       Impact factor: 2.778

10.  Comparison of the therapeutic effects of 15 mg and 30 mg initial dosage of prednisolone daily in patients with subacute thyroiditis: protocol for a multicenter, randomized, open, parallel control study.

Authors:  Shaoyong Xu; Yuxin Jiang; Aihua Jia; Juan Zhang; Bin Gao; Jing Xu; Xiaorui Jing; Yang Jiao; Jia Wei; Wenlei Xu; Ruikun Chen; Ling Gao; Lei Shang
Journal:  Trials       Date:  2020-05-24       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.